Inhibition of bone resorption by the bisphosphonate BM 21.0955 is not associated with an alteration of the renal handling of calcium in rats infused with parathyroid hormone-related protein
- 31 August 1992
- Vol. 13 (4) , 321-325
- https://doi.org/10.1016/8756-3282(92)90077-a
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemiaBone, 1991
- BM 21.0955, a potent new bisphosphonate to inhibit bone resorptionJournal of Bone and Mineral Research, 1991
- High extracellular calcium increases the production of a parathyroid hormone-like activity by cultured leydig tumor cells associated with humoral hypercalcemiaJournal of Bone and Mineral Research, 1989
- Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in ratsJournal of Bone and Mineral Research, 1989
- Hypercalcemia of malignancy revisited.Journal of Clinical Investigation, 1988
- Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronateBone, 1988
- Hypercalcemia induced with an arotinoid in thyroparathyroidectomized rats. New model to study bone resorption in vivo.Journal of Clinical Investigation, 1987
- Role of bone and kidney in tumor-induced hypercalcemia and its treatment with bisphosphonate and sodium chlorideThe American Journal of Medicine, 1987
- Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.BMJ, 1986
- Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.BMJ, 1984